According to a new report published by OG Analysis, the global AI in Cell and Gene Therapy Development Market was valued at USD 520 million in 2026 and is projected to reach USD 3.87 billion by 2034, expanding at a CAGR of 28.5% during the forecast period.
Market Overview
The market is emerging as a high-value digital life sciences segment as advanced-therapy developers seek faster, more...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek